March 28th, 2022

On 3/19/2022 1:51 PM, Kramer Communications wrote:

Join Us: Registration is Still Open

The Chondrosarcoma Foundation, Inc. will host their fourth International Forum / Virtual Dialogue featuring the following prominent experts to address new…

March 24th, 2022

Individual Coalition member organizations – Informing their patient communities – offering information for patients and families to donate to this cause should they wish to do so. The Sarcoma Coalition wishes to initiate advocacy/action for a…

‘He left with no regrets.’ Tri-Cities grad with cancer found connection on TikTok, Instagram BY ERIC ROSANE UPDATED MARCH 23, 2022 11:16 AM

Friends and family look back on the life of Parker Morgan, a 21-year-old Kennewick native who died this…

March 23rd, 2022

Reaching out to all rare cancer groups/advocates/patients. April 26, 2022. Virtual & in-person event from Columbia U Herbert Irving Cancer Center, NYC – “Rare Cancers: Great Unmet Medical Needs”. It’s a CME conference for patients/advocates/PAGs…

The Precision Oncology Screening Platform Enabling Clinical Trials (PrOSPeCT) will establish Australia as a medical manufacturing hub: building links from research through to the clinic; creating jobs; changing lives.

Professor David Thomas

Media…

March 19th, 2022

Join Us: Registration is Still Open

The Chondrosarcoma Foundation, Inc. will host their fourth International Forum / Virtual Dialogue featuring the following prominent experts to address new innovations, findings and technologies to improve the…

March 18th, 2022

The Johns Hopkins Department of Pathology is proud to announce the launch of a new web site, “Clinical Pathology Unknowns” (https://apps.pathology.jhu.edu/cp/), an interactive clinical pathology educational resource. This…

March 6th, 2022

The Chondrosarcoma Foundation, Inc. will host their fourth International Forum / Virtual Dialogue: Moving Forward in Diagnosing and Treating Chondrosarcoma.

In the spirit of sharing and passing knowledge about Chondrosarcoma, we invite you to…

February 23rd, 2022

The Chondrosarcoma Foundation, Inc. will host their fourth International Forum / Virtual Dialogue featuring the following prominent experts to address new innovations, findings and technologies to improve the treatment of Chondrosarcoma.

Anthony P….

February 20th, 2022

About 20% of people with chondrosarcoma responded to the drug (tumor shrinkage by 20%).

On average people with CS were on the drug for about 4-5 months before it was deemed ineffective though.

In looking at the criteria for CS patients on the…